Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

Mutant peptides presented by cancer cells are superior vaccine candidates than self peptides. The efficacy of mutant K-Ras, P53 and EGFR (Epidermal Growth Factor Receptor) peptides have been tested as cancer v...

Source: BMC Immunology - November 13, 2019 Category: Allergy & Immunology Authors: Deng Pan, Dapeng Zhou, Weijing Cai, Weibo Wu, Wen Ling Tan, Caicun Zhou and Yanyan Lou Tags: Research article Source Type: research